Company developing a cell-free DNA (cfDNA) capture device designed to transform liquid biopsy testing for cancer management
Biocaptiva Ltd has raised €4.3M across 2 funding rounds from 6 investors, most recently a round in Mar 2026. Based in Edinburgh, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
